Evan H. Goulding, MD, PhD; Cynthia A. Dopke, PhD; Rebecca Rossom, MD, MS; et al.
free access
JAMA Psychiatry. 2023;80(2):109-118. doi:10.1001/jamapsychiatry.2022.4304
This randomized clinical trial investigates the effects of a smartphone-based self-management intervention for bipolar disorder on relapse risk, symptoms, and quality of life.
Tara A. Niendam, PhD; Rachel Loewy, PhD; Mark Savill, PhD; et al.
free access
has audio
JAMA Psychiatry. 2023;80(2):119-126. doi:10.1001/jamapsychiatry.2022.4436
This cluster randomized clinical trial assesses whether the use of population-based electronic screening in addition to standard targeted clinician education increases the early detection of psychosis and decreases the duration of untreated psychosis, compared with clinician education alone.
-
Podcast:
Effect of Technology-Enhanced Screening Plus Standard Clinician Education on the Duration of Untreated Psychosis
Jonathan Zandberg, PhD; Rebecca Waller, PhD; Elina Visoki, MSc; et al.
free access
JAMA Psychiatry. 2023;80(2):127-134. doi:10.1001/jamapsychiatry.2022.4394
This cohort study analyzes suicide rates among reproductive-aged women from 1974 to 2016 to determine their association with state-level legislative policies surrounding abortion and restricted access to reproductive care.
Nathan A. Kimbrel, PhD; Allison E. Ashley-Koch, PhD; Xue J. Qin, PhD; et al.
free access
JAMA Psychiatry. 2023;80(2):135-145. doi:10.1001/jamapsychiatry.2022.3896
This genome-wide association study including 633鈥�778 US military veterans evaluates potential genetic risk loci for suicidal thoughts and behaviors among US military veterans.
Rosa Lundbye Allesøe, MSc; Wesley K. Thompson, PhD; Jonas Bybjerg-Grauholm, PhD; et al.
free access
JAMA Psychiatry. 2023;80(2):146-155. doi:10.1001/jamapsychiatry.2022.4076
This diagnostic study investigates if a prediction of mental health diagnosis and subsequent severity trajectories can be made using national Danish health registry and genetic data.
Krista F. Huybrechts, MS, PhD; Loreen Straub, MD, MS; Pär Karlsson, MSc; et al.
free access
JAMA Psychiatry. 2023;80(2):156-166. doi:10.1001/jamapsychiatry.2022.4109
This cohort study evaluates the risk of first-trimester antipsychotic exposure with respect to congenital malformations, focusing on individual drugs and specific malformation subtypes.
Johan Lundberg, MD, PhD; Thomas Cars, PhD; Sven-Åke Lööv; et al.
open access
JAMA Psychiatry. 2023;80(2):167-175. doi:10.1001/jamapsychiatry.2022.3860
This cohort study examines data for episodes of unipolar major depressive disorder that met criteria for treatment-resistant depression to assess its impact on individuals and society and consider potential prognostic factors.